Halozyme Therapeutics Corporate Presentation May 2023

Halozyme is a biopharmaceutical company that licenses its ENHANZE® drug delivery platform to partners for subcutaneous administration of therapeutic drugs. The company has 5 globally-approved partnered products approved in over 100 countries, with approximately 700,000 patients having received ENHANZE-enabled treatments. Halozyme also commercializes specialty products and develops auto-injector devices and formulations for expanded intellectual property protection.